Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
6915-57-7
Molecular formula
C6HBiBr4O3
Molecular weight
649.67 g/mol
Drug class
Bismuth-containing topical ophthalmic antiseptic and astringent
Mechanism of action
Exerts local antiseptic and astringent effects through protein precipitation and interaction with microbial surface components. The exact contribution of bismuth and the organic ligand depends on the formulation.
Indications / reported uses
Topical treatment of selected superficial inflammatory and infectious conditions of the eyelid and conjunctiva in countries where bibrocathol ophthalmic products are authorised
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Bibrocathol PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Bibrocathol Permitted Daily Exposure (PDE) report (the Bibrocathol PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Bibrocathol Occupational Exposure Limit (OEL) report (the Bibrocathol OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.